Etanercept up for FDA review to treat psoriasis: it could be the first anti-TNF biologic to earn agency approval for psoriasis: process can take up to … An article from: Skin & Allergy News
Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2003. The length of the article is 661 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after buy. You can view it with any web browser.
Citation Details
Title: Etanercept up for FDA review to treat psoriasis: it could be the first anti-TNF biologic to earn agency approval for psoriasis: process can take up to 1 year.(News)
Author: Elizabeth Mechcatie
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2003
Publisher: International Medical News Group
Volume: 34 Issue: 8 Page: 1(2)
Distributed by Thomson Gale
